financetom
Business
financetom
/
Business
/
Moneycontrol Pro Ideas for Profit: Here's why Bata sales may improve
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Moneycontrol Pro Ideas for Profit: Here's why Bata sales may improve
Jan 21, 2021 6:30 AM

In Ideas for Profit from Moneycontrol pro, Bharat Gianani of Moneycontrol.Com, spoke about a stock that he is tracking closely, Bata India.

Share Market Live

NSE

The discretionary consumer company has strengthened its premium portfolio by introducing new products under Hush Puppies and Scholl for the men segment. For the women segment, new products have been introduced under Naturalizer and Marie Claire brand. The company is also focusing on youth by introducing casual footwear and more fashionable colours.

The company is expanding its distribution from tier-III and tier-IV towns and is opening 500 new franchises, which will increase the contribution from the rural and semi-urban space.

Further improvement in sales is expected.

For more, watch the video

(Edited by : Ajay Vaishnav)

First Published:Jan 21, 2021 3:30 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ATS Q2 Earnings Fall on Lower Transportation Revenue as Company Battles With Shift in EV Markets
ATS Q2 Earnings Fall on Lower Transportation Revenue as Company Battles With Shift in EV Markets
Nov 6, 2024
06:27 AM EST, 11/06/2024 (MT Newswires) -- ATS (TSX and NYSE: ATS) on Wednesday reported a drop in earnings for the second quarter on lower transportation revenues as it tries to come to terms with shifting customer investment trends in North American electric vehicle production. In an update on large EV customer projects, ATS management continues to expect that transportation...
Novo Nordisk affirms 25% weight-loss expectation for experimental drug CagriSema
Novo Nordisk affirms 25% weight-loss expectation for experimental drug CagriSema
Nov 6, 2024
* Data on late-stage CagriSema trial expected by end of 2024 * Novo still confident on 25% weight loss potential -Lange * Data a 'must win' for Novo obesity-driven investments-analysts (Adds quotes, details, from paragraph 4) By Maggie Fick LONDON, Nov 6 (Reuters) - Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema...
Trump return will slow, not stop, US clean energy boom
Trump return will slow, not stop, US clean energy boom
Nov 6, 2024
(Reuters) - Donald Trump's return to the White House will refocus the nation's energy policy onto maximizing oil and gas production and away from fighting climate change, but the Republican win in Tuesday's presidential elections is unlikely to dramatically slow the U.S. renewable energy boom. That is because a Biden-era law providing a decade of lucrative subsidies for new solar,...
Celsius Holdings Posts Breakeven Q3 Earnings as Revenue Falls
Celsius Holdings Posts Breakeven Q3 Earnings as Revenue Falls
Nov 6, 2024
06:24 AM EST, 11/06/2024 (MT Newswires) -- Celsius Holdings ( CELH ) on Wednesday reported breakeven Q3 earnings per diluted share, compared with earnings of $0.30 a year earlier. Analysts polled by Capital IQ expected earnings of $0.01. Revenue for the quarter ended Sept. 30 was $265.7 million, down from $384.8 million a year earlier. Analysts surveyed by Capital IQ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved